Skip to content

Trial of Probiotics for Constipation in Parkinson's Disease

A Randomized Double-Blinded Placebo-Controlled Trial of Probiotics for Constipation in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03377322
Enrollment
72
Registered
2017-12-19
Start date
2017-12-01
Completion date
2019-01-31
Last updated
2019-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

This is a double blinded randomised placebo controlled trial to evaluate the efficacy of probiotics in the treatment of constipation in Parkinson's disease.

Interventions

Probiotic - one capsule a day for four weeks

DRUGPlacebo Capsule

Placebo - one capsule a day for four weeks

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double blinded

Intervention model description

Placebo Controlled

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age 50 to 80 years old * Provision of written informed consent * Diagnosis of PD made by a Neurologist using UK Brain Bank Criteria * Fulfils criteria for functional constipation according to the Rome IV Criteria during in the preceding 6 months with frequency of bowel movements less than 3 times per week

Exclusion criteria

* Ingestion of probiotics in the preceding 4 weeks * Use of antibiotics in the preceding 4 weeks * History of gastrointestinal disorders or surgery * Known or suspected allergy to probiotics * Comorbidities that prevent reliable completion of study assessments * Prior functional neurosurgery for PD or treatment with apomorphine infusion * Recent initiation of dopaminergic medications in the preceding 3 months

Design outcomes

Primary

MeasureTime frameDescription
Change in frequency of bowel opening per weekWeek 4 post randomisationAverage number of bowel opening per week based on stool diary

Secondary

MeasureTime frameDescription
Change in stool consistencyWeek 4 post randomisationAverage stool consistency based on Bristol stool chart that was included in the stool diary
Change in constipation severity scoreWeek 4 post randomisationTotal score of a constipation severity questionnaire adapted from ROME IV criteria for functional constipation. This scale evaluates the severity of five parameters related to constipation which include straining during defecation, lumpy or hard stools, sensation of incomplete evacuation, manual manoeuvres to facilitate defecations and spontaneous bowel movements per week. Each parameter is scored from 0 to 3, with 3 indicating the worst severity.
Change in patient's quality of life in relation to constipationWeek 4 post randomisationTotal score of PAC-QOL questionnaire (Marquis et al, Scandinavian J of Gastroenterology 2008). This scale has a total of 28 items evaluating four different constructs related to quality of life which include worries/concerns, physical discomfort, psychosocial discomfort and patient's satisfaction. Each item is scored from 1 to 5, with 5 indicating the worst severity.

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026